Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. WMT
3. ROST
4. EL
5. SPY
6. BILL
7. ADI
8. MRK
9. MRNA
10. NTES

Go back to Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
(NASDAQ: ABVX) Delayed: 118.20 +0.01 (0.01%)
Previous Close $118.19    52 Week High $ 
Open $118.20    52 Week Low $ 
Day High $118.20    P/E N/A 
Day Low $118.20    EPS $ 
Volume 994       

(NASDAQ: ABVX) Delayed: 118.20 +0.01 (0.01%)
Previous Close $118.19    52 Week High $ 
Open $118.20    52 Week Low $ 
Day High $118.20    P/E N/A 
Day Low $118.20    EPS $ 
Volume 994